New Patents Granted to Sabinsa’s Cosmetics Division in US And EU
Sabinsa Cosmetics, a division of the Sami Labs – Sabinsa Group, has been granted two new patents on novel cosmetic compositions, both developed from extensive research on combinations of the companies branded ingredients. These most recent patents are likely to fuel the company’s rapid growth in the cosmetic industry given the high demand for sunscreen lotions and hair growth formulations.
United States patent US 9498423 describes a synergistic composition comprising of β – glucogallin (1-O-galloyl-β-D-glucose) or β – glucogallin and total gallates from Amla (Saberry®), concentrate of liquid endosperm of Cocos nucifera (Cococin®) and the selenopeptides (γ-L-glutamyl-Se-methyl-L-selenocysteine, and γ-L-glutamyl- L-selenomethionine) for maintaining the morphology and numbers of the dermal papilla cells when exposed to stress signals. The composition protects the dermal papilla cells from stress signals (UVB radiation), and the numbers of live dermal papilla cells are maintained at a level of 95% or more when the dermal papilla cells are exposed to UVB radiation levels ranging from 0.8 J/cm2 to 1.0 J/cm2. This composition has also been patented in Europe (EP2695603), Japan (JP6064274), New Zealand (NZ600307) and Russia (RU2606752).
Sabinsa’s cosmetic division has also received a patent in Europe (EP2461786) for a composition comprising β – glucogallin (1-O-galloyl-β-D-glucose) Amla (Saberry®) and concentrate of liquid endosperm of Cocos nucifera (Cococin®) for promoting hair growth. This composition also protects dermal papilla cells from UV rays. The invention has previously been granted a patent in in Australia (AU2010326651).